CTOR — CITIUS ONCOLOGY INC

Ownership history in XTX Topco Ltd  ·  3 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in CITIUS ONCOLOGY INC (CTOR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.01%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 73,992 -52,892 -41.7% 0.00% $74K $1.00
2025 Q3 ADDED 126,884 +105,789 +501.5% 0.01% $258K $2.03
2024 Q4 INITIATED 21,095 — — 0.00% $24K $1.15
% of Fund (quarterly)    CTOR price (monthly, adj. close)

Other funds also holding CTOR

As of 2025 Q4 — sorted by position size

ARMISTICE CAPITAL, LLC 3Y 7Y 0.07% IFP Advisors, Inc 3Y 7Y 0.0% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0% Arkadios Wealth Advisors 3Y 0.0% Versant Capital Management, Inc 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% OSAIC HOLDINGS, INC. 3Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0%
← Back to XTX Topco Ltd Holdings